Ledger.Open graph →

SEC Form D · filed March 15, 2018

ViewPoint Therapeutics, Inc

Offering

$35.0M

Sold

$20.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Leah Makley · San Francisco, CAExec · Director Ed Hurwitz · San Francisco, CADirector Emmett T. Cunningham, Jr · San Francisco, CADirector Peter T. Moldt · BRISBANE, CADirector Heath T. Lukatch · San Francisco, CADirector Glen C. Dailey · New York, NYDirector Robert E. Enslein, Jr · New York, NYExec · Director Susan Bailey · Fort Collins, CODirector Robert K. Lewis · Austin, TXDirector Raul C. Romero · Austin, TXDirector Michelle G. Gottlieb · Chicago, ILExec · Director Peter T. Moldt · BRISBANE, CADirector Heath T. Lukatch · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗